Term
| Brand name for Clindamycin |
|
Definition
|
|
Term
|
Definition
Reversibly binds to the 50s ribosomal subunit and inhibits bacteral protein synthesis.
|
|
|
Term
| Antibiotic activity of clindamycin |
|
Definition
| most gram (+), not enterococcus, and anaerobes |
|
|
Term
| Black box wraning for Clindamycin |
|
Definition
| can cause severe and possible fatal colitis |
|
|
Term
| Brand name for metronidazole |
|
Definition
|
|
Term
|
Definition
Causes a loss of helical DNA structure and inhibits protein synthesis.
|
|
|
Term
| Antibiotic activity of metronidazole |
|
Definition
activity against anaerobes and protozoal infections
|
|
|
Term
| Metronidazole is DOC for what? |
|
Definition
Bacterial vaginosis
Trichomoniasis
Giardiasis
Amoebiasis
Pseudomembranous Colitis |
|
|
Term
| Brand name for Tinidazole |
|
Definition
|
|
Term
| antibiotic activity for tinidazole |
|
Definition
| activity agaisnt protozoa and bacterial vaginosis organisms |
|
|
Term
| tinidazole can cause what kind of reaction? |
|
Definition
| disulfram - like reactions |
|
|
Term
|
Definition
|
|
Term
| what is the main purpose of rifaximin |
|
Definition
| treatment of traveler's diarrhea caused by non-invasive E. Coli |
|
|
Term
| Brand name for Fosfomycin |
|
Definition
|
|
Term
|
Definition
| bacterial cell wall inhibitor |
|
|
Term
| What is fosfomycin used for |
|
Definition
| single dose used to treat uncomplicated UTI due to E. Coli and E. Faecalis |
|
|
Term
| Brand name for Nitrofuratoin |
|
Definition
|
|
Term
|
Definition
| bacterial cell wall inhibitor |
|
|
Term
| primary use of nitrofuratoin |
|
Definition
Used for UTI due to E. Coli, S. aureus, Enterococcous, Klebsiella and Enterobacter |
|
|
Term
| Contraindication for Nitrofuratoin |
|
Definition
in patients with renal impairment (CrCL< 60 ml/min) and pregnancy at term. |
|
|
Term
| Instructions for nitrofuratoin administration. |
|
Definition
| Take with food. Enhances absorption. |
|
|
